» Articles » PMID: 30400570

Multispecies Probiotic Supplementation Favorably Affects Vascular Function and Reduces Arterial Stiffness in Obese Postmenopausal Women-A 12-Week Placebo-Controlled and Randomized Clinical Study

Overview
Journal Nutrients
Date 2018 Nov 8
PMID 30400570
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity in the postmenopausal period is associated with an increased risk of cardiovascular diseases in women. One of the key drivers of cardiovascular risk is endothelial dysfunction; thus, this is also a crucial point for studies on new therapeutic methods of cardioprotective properties. The aim of the current study was to evaluate the effect of two doses of multispecies probiotic Ecologic Barrier supplement on functional (primary endpoint) and biochemical parameters (secondary endpoint) of endothelial dysfunction in obese postmenopausal women in a 12-week randomized, placebo-controlled clinical trial. A total of 81 obese Caucasian women participated in the trial. The subjects were randomly assigned to three groups that received a placebo, a low dose (LD) (2.5 × 10⁸ colony forming units (CFU) per day), or a high dose (HD) (1 × 10 CFU per day) of lyophilisate powder containing live multispecies probiotic bacteria. The probiotic supplement was administered each day for 12 weeks in two equal portions. A high dose probiotic supplementation for 12 weeks decreased systolic blood pressure, vascular endothelial growth factor, pulse wave analysis systolic pressure, pulse wave analysis pulse pressure, pulse wave analysis augmentation index, pulse wave velocity, interleukin-6, tumor necrosis factor alpha, and thrombomodulin. Low doses of probiotic supplementation decreased the systolic blood pressure and interleukin-6 levels. The mean changes in the estimated parameters, compared among the three groups, revealed significant differences in the vascular endothelial growth factor, the pulse wave analysis systolic pressure, the pulse wave analysis augmentation index, the pulse wave velocity, the tumor necrosis factor alpha, and thrombomodulin. The post hoc tests showed significant differences for all parameters between HD and the placebo group, and HD and LD (besides pulse wave analysis augmentation index). We show for the first time that supplementation with multispecies probiotic Ecologic Barrier favorably modifies both functional and biochemical markers of vascular dysfunction in obese postmenopausal women.

Citing Articles

Probiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease.

Lopez-Yerena A, de Santisteban Villaplana V, Badimon L, Vilahur G, Padro T Nutrients. 2025; 17(1.

PMID: 39796486 PMC: 11722674. DOI: 10.3390/nu17010052.


Bacterial live therapeutics for human diseases.

Frutos-Grilo E, Ana Y, Gonzalez-de Miguel J, Cardona-I-Collado M, Rodriguez-Arce I, Serrano L Mol Syst Biol. 2024; 20(12):1261-1281.

PMID: 39443745 PMC: 11612307. DOI: 10.1038/s44320-024-00067-0.


Impact of and Its Combination with Isoflavone Products on Calcium Status, Calcium Transporters, and Bone Metabolism Biomarkers in a Post-Menopausal Osteoporotic Rat Model.

Harahap I, Schmidt M, Pruszynska-Oszmalek E, Sassek M, Suliburska J Nutrients. 2024; 16(15).

PMID: 39125403 PMC: 11314490. DOI: 10.3390/nu16152524.


Microbial-Based Bioactive Compounds to Alleviate Inflammation in Obesity.

Apalowo O, Adegoye G, Obuotor T Curr Issues Mol Biol. 2024; 46(3):1810-1831.

PMID: 38534735 PMC: 10969769. DOI: 10.3390/cimb46030119.


Influence of Isoflavones and Probiotics on Magnesium Status in Healthy Female Rats.

Harahap I, Kuligowski M, Schmidt M, Kurzawa P, Suliburska J Foods. 2023; 12(21).

PMID: 37959026 PMC: 10647356. DOI: 10.3390/foods12213908.


References
1.
Laurent S, Kingwell B, Bank A, Weber M, Struijker-Boudier H . Clinical applications of arterial stiffness: therapeutics and pharmacology. Am J Hypertens. 2002; 15(5):453-8. DOI: 10.1016/s0895-7061(01)02329-9. View

2.
Eom T, Kim Y, Choi C, Sadowsky M, Unno T . Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease. J Microbiol. 2018; 56(3):189-198. DOI: 10.1007/s12275-018-8049-8. View

3.
Jafarnejad S, Saremi S, Jafarnejad F, Arab A . Effects of a Multispecies Probiotic Mixture on Glycemic Control and Inflammatory Status in Women with Gestational Diabetes: A Randomized Controlled Clinical Trial. J Nutr Metab. 2016; 2016:5190846. PMC: 4939193. DOI: 10.1155/2016/5190846. View

4.
Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T . Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study. Scand J Rheumatol. 2003; 32(4):211-5. DOI: 10.1080/03009740310003695. View

5.
Li W, Yang S, Kim S, Reid G, Challis J, Bocking A . Lipopolysaccharide-Induced Profiles of Cytokine, Chemokine, and Growth Factors Produced by Human Decidual Cells Are Altered by Lactobacillus rhamnosus GR-1 Supernatant. Reprod Sci. 2014; 21(7):939-947. PMC: 4107568. DOI: 10.1177/1933719113519171. View